-
Mashup Score: 38
See a new #breastcancer activity via @PeerView @DrSGraff #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38
See a new #breastcancer activity via @PeerView @DrSGraff #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
🧵Welcome to a fun & informative 3-part #Xthread on how to make 🎯decisions in HR+, HER2- #MBC, based on a case-based #CME activity I developed with @PeerView 👉https://t.co/HzHn3VOigc. I’ll post 3 case scenarios with polls 📊, you vote 📲, and we’ll discuss each case. Ready? https://t.co/oCJ5QG3C2x
-
-
Mashup Score: 38
See a new #breastcancer activity via @PeerView @DrSGraff #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
🧵Welcome to a fun & informative 3-part #Xthread on how to make 🎯decisions in HR+, HER2- #MBC, based on a case-based #CME activity I developed with @PeerView 👉https://t.co/HzHn3VOigc. I’ll post 3 case scenarios with polls 📊, you vote 📲, and we’ll discuss each case. Ready? https://t.co/oCJ5QG3C2x
-
-
Mashup Score: 35
See a new #breastcancer activity via @PeerView @DrSGraff #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
🧵Welcome to a fun & informative 3-part #Xthread on how to make 🎯decisions in HR+, HER2- #MBC, based on a case-based #CME activity I developed with @PeerView 👉https://t.co/HzHn3VOigc. I’ll post 3 case scenarios with polls 📊, you vote 📲, and we’ll discuss each case. Ready? https://t.co/oCJ5QG3C2x
-
-
Mashup Score: 11Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond - 3 month(s) ago
See the latest #HCM live event from @PeerView @DesaiMilindY @tikuowens #HFSA2024 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Partners & KOLsTweet-
Happening TOMORROW! HFSA Education Partner Program: Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM & Beyond. Discover More >> https://t.co/Ohgm8w90rf https://t.co/KCzB2aOSmr
-
-
Mashup Score: 12Don’t Fail Them Now: Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis - 4 month(s) ago
See the latest #ATTRCA #CardiacAmyloidosis live event from @PeerView @senthil_selv #HFSA2024 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Partners & KOLsTweet-
Happening 12/3! HFSA Education Partner Program: Don't Fail Them Now: Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis. Discover More >> https://t.co/WRV5ny2AP4 https://t.co/9bL8I9UCzm
-
-
Mashup Score: 28Refining the First Strike Against EGFR-Mutated Advanced NSCLC: Personalizing Frontline Treatment Decisions Amid Increasing Complexity - 4 month(s) ago
See the latest #EGFR-mutated #NSCLC live event from @PeerView at MaTOS #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
Join us this Friday, Nov 22nd, 9:30am PST to discuss 1L therapy for #EGFR NSCLC, at the #MaTOS meeting or virtually. I'll discuss the options with Dr. @ZPiotrowskaMD in this free 1h #CME #MOC activity with @PeerView. Hope to see you there! https://t.co/5RpPnr4bWm https://t.co/6FmXdJFj5r
-
-
Mashup Score: 2Smart Steps for Effective Real-World Care in RCC: Enhancing Outcomes in Advanced Disease - 4 month(s) ago
See the latest #RCC live event from @PeerView @montypal @tiansterzhang #IKCSNA24 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
RT @QianJanieQin: Join us in person or #virtually at https://t.co/y0V8wz4fkY for a lively discussion with @TiansterZhang #Dr. Nazar Tannir…
-
-
Mashup Score: 2Smart Steps for Effective Real-World Care in RCC: Enhancing Outcomes in Advanced Disease - 4 month(s) ago
See the latest #RCC live event from @PeerView @montypal @tiansterzhang #IKCSNA24 #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
RT @QianJanieQin: Join us in person or #virtually at https://t.co/y0V8wz4fkY for a lively discussion with @TiansterZhang #Dr. Nazar Tannir…
-
-
Mashup Score: 52PeerView - Refining the First Strike Against EGFR-Mutated Advanced NSCLC: Personalizing Frontline Treatment Decisions Amid Increasing Complexity - 4 month(s) ago
See the latest #EGFR-mutated #NSCLC live event from @PeerView at MaTOS #MedEd
Source: lrn.peerview.comCategories: General Medicine News, Hem/OncsTweet-
Join me and Dr. @ZPiotrowskaMD on Friday, November 22nd at 9:30am PST as we discuss first-line management of #EGFR NSCLC as part of the MaTOS conference in Lake Tahoe, CA. Join us in person for breakfast or virtually! https://t.co/r5hwyWA5Np https://t.co/T2Gts117U1
-
🧵Welcome to a fun & informative 3-part #Xthread on how to make 🎯decisions in HR+, HER2- #MBC, based on a case-based #CME activity I developed with @PeerView 👉https://t.co/HzHn3VOigc. I’ll post 3 case scenarios with polls 📊, you vote 📲, and we’ll discuss each case. Ready? https://t.co/oCJ5QG3C2x